How Quickly Are Patients Reaching Quadruple HFrEF Therapy? - Top_Thought_Leaders - MDSpire

How Quickly Are Patients Reaching Quadruple HFrEF Therapy?

Delays in initiating guideline-directed quadruple therapy may increase early clinical risk in heart failure with reduced ejection fraction.

  • By

  • Kathryn Wighton

  • June 8, 2026

  • 5 min

Share

Top Thought Leaders in Pathology

Brief introduction explaining scope and methodology.

Original Source(s)

How Quickly Are Patients Reaching Quadruple HFrEF Therapy?

  • by Kathryn Wighton

  • June 8, 2026

Related Content

Independent prognostic value of the triglyceride–glucose index and its incremental predictive contribution beyond traditional risk markers in acute heart failure: a retrospective cohort study

Efficacy and safety of FangJiHuangQi granule in patients with heart failure: a protocol of randomized, placebo-controlled trial

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.